Fig. 1.

Fig. 1. Construction of an immune lncRNA signature for liver hepatocellular carcinoma. (A) The network of partial immune genes and associated lncRNAs. B. Candidate lncRNA for the prognostic model with information about hazard ratio. (C) Relative gene expression of MSC-AS1 among the low-risk group, high-risk group, and non-tumor samples. (D) Relative gene expression of AC009005.1 among the low-risk group, high-risk group, and non-tumor samples. (E) Relative gene expression of AL365203.2 among the low-risk group, high-risk group, and non-tumor samples. (F) Relative gene expression of AC099850.3 among the low-risk group, high-risk group, and non-tumor samples. (G) Relative gene expression of AL031985.3 among the low-risk group, high-risk group, and non-tumor samples. (H) Relative gene expression of AL117336.3 among the low-risk group, high-risk group, and non-tumor samples.

© J. Microbiol. Biotechnol.